ESSILOR INTERNATIONAL /FI
ESLOF
|
$214.88
0.76%
-23.31%
0
|
Health Technology
(0.0% 1d) (-5.4% 1m) (9.7% 1y) (0.0% 2d) (0.0% 3d) (-0.4% 7d) (27.48% volume)
Earnings Calendar:
Market Cap: $ 97,522,689,559
http://www.essilorluxottica.com
Sec Filling | Patents | n/a employees
(FR) EssilorLuxottica SA engages in the design, manufacture, and sales of ophthalmic lenses and instruments. It operates through the following business segments: Lenses & Optical Instruments, Equipment, and Sunglasses and Readers. The Lenses & Optical Instruments business segment engages in the production, finishing, distribution and trading of lens and instruments. The Equipment business segment includes production, distribution and sale of high capacity equipment, such as digital surfacing machines and lens polishing machines, which are used in manufacturing plants and prescription laboratories for finishing operations on semi-finished lenses. The Sunglasses and Readers business segment engages in the production, distribution and sale of both non-prescription sunglasses and non-prescription reading glasses. The company was founded by Leonardo Del Vecchio in 1961 and is headquartered in Charenton-le-Pont, France.
optical
add to watch list Paper trade email alert is off
Chugai Pharmaceutical Co., Ltd. / ADR
CHGCF
|
$33.27
-36.83%
110
|
Health Technology
(0.0% 1d) (-15.0% 1m) (28.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (1088.89% volume)
Earnings Calendar:
Market Cap: $ 55,862,248,581
http://www.chugai-pharm.co.jp
Sec Filling | Patents | n/a employees
(JP) Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.
add to watch list Paper trade email alert is off
NOVOZYMES AS/FI
NVZMF
|
$52.71
-3.28%
-8.66%
0
|
Health Technology
(0.0% 1d) (-13.4% 1m) (1.0% 1y) (0.0% 2d) (-3.3% 3d) (-5.5% 7d) (580.56% volume)
Earnings Calendar:
Market Cap: $ 21,851,196,475
http://www.novozymes.com
Sec Filling | Patents | n/a employees
(DK) Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark.
urea agricultural agriculture
add to watch list Paper trade email alert is off
Straumann Holding AG / ADR
SAUHF
|
$142.304
-5.13%
-15.92%
0
|
Health Technology
(0.0% 1d) (-4.3% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.6% 7d) (-23.03% volume)
Earnings Calendar:
Market Cap: $ 22,691,118,331
http://www.straumann.com
Sec Filling | Patents | n/a employees
(CH) Straumann Holding AG engages in the provision of implant, restorative, and regenerative dentistry solutions to dental professionals and laboratories. It operates through the following segments: Sales Europe, Sales Distributor & Emerging Markets EMEA, Sales NAM, Sales APAC, Sales LATAM, and Operations. The Sales Europe segment comprises of the Group's premium and Instradent distribution business. The Sales Distributor & Emerging Markets EMEA segment consists of premium and Instradent distribution businesses in Russia, as well as the premium business with European, African, and Middle Eastern distributors. The Sales NAM segment includes ClearCorrect’s clear-aligner business and its associated development and production activities. The Sales APAC involves in the distribution business of Anthogyr implants and prosthetic components in China and the Equinox implants in India. The Sales LATAM segment includes distribution and Instradent businesses in Middle and South America, and Latin America. The Operations segment manufactures plants, implants, and biomaterials. The company was founded by Reinhard Straumann in 1954 and is headquartered in Basel, Switzerland.
spac
add to watch list Paper trade email alert is off
Sysmex Corporation/ADR
SSMXF
|
$15.949
0.39%
1.1K
|
Health Technology
(0.0% 1d) (-71.3% 1m) (-76.6% 1y) (0.0% 2d) (-3.3% 3d) (0.0% 7d) (-95.51% volume)
Earnings Calendar:
Market Cap: $ 10,037,329,561
http://www.sysmex.co.jp
Sec Filling | Patents | n/a employees
(JP) Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. It also provides clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. It operates through the following geographical segments: Japan, Americas, Europe, Middle East, and Africa (EMEA), China, and Asia Pacific. The company was founded by Taro Nakatani on February 20, 1968 and is headquartered in Kobe, Japan.
diagnostics
add to watch list Paper trade email alert is off
Sonova Holding AG / ADR
SONVF
|
$281.7
-10.2%
210
|
Health Technology
(0.0% 1d) (-7.3% 1m) (-13.9% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (5150.0% volume)
Earnings Calendar:
Market Cap: $ 16,796,872,095
http://www.sonova.com
Sec Filling | Patents | n/a employees
(CH) Sonova Holding AG engages in the development and production of hearing care solutions. It operates through the Hearing Instruments and Cochlear Implants business segments. The Hearing Instruments segment includes the activities related to the design, development, production, distribution, and servicing of hearing instruments and related products. The Cochlear Implants segment involves the activities relevant to the design, development, production, distribution, and servicing of hearing implants and related products. The firm offers its products under the brands Phonak, Unitron, Hansaton, Connect Hearing, Boots Hearingcare, AudioNova, Geers, and Advanced Bionics. The company was founded in 1947 and is headquartered in Staefa, Switzerland.
brands
add to watch list Paper trade email alert is off
Otsuka Holdings Co., Ltd./ADR
OTSKF
|
$38.358
-11.7%
100
|
Health Technology
(0.0% 1d) (0.0% 1m) (8.3% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (0.0% volume)
Earnings Calendar:
Market Cap: $ 21,397,458,597
http://www.otsuka.com
Sec Filling | Patents | n/a employees
(JP) Otsuka Holdings Co., Ltd. engages in the manufacture and sale of pharmaceuticals and nutritional supplements. It operates through the following business segments: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others. The Pharmaceuticals segment manufactures therapeutic drugs and infusions focusing on the central nervous system, oncology, and infectious diseases. The Nutraceuticals segment develops and markets nutrition products such as nutritional food, quasi-drugs, health drinks, and dietary supplements for homes, medical facilities, and nursing care units. The Consumer Products segment sells mineral water, food, and beverages. Its products include Bon Curry, Mannan Hikari, and ReSOLA. The Others segment distributes functional and fine chemicals, optical inspection devices, and clinical diagnosis equipment. The company was founded in1950 and is headquartered in Tokyo, Japan.
diagnostics infectious disease nervous system optical
add to watch list Paper trade email alert is off
ALTERITY THERAPEUTICS LTD
PRNAF
|
$0.0002
-90.0%
11450.0%
0
|
Health Technology
(0.0% 1d) (0.0% 1m) (-95.9% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (192.0% volume)
Earnings Calendar:
Market Cap: $ 14,901,366
http://www.pranabio.com
Sec Filling | Patents | n/a employees
(AU) Alterity Therapeutics Ltd. engages in the development of therapeutic drugs designed to treat the underlying causes of degeneration of the brain as the aging process progresses. It focuses on Parkinson's movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Melbourne, Australia.
parkinson alzheimer neurodegenerative alzheimer’s
add to watch list Paper trade email alert is off
JUVA LIFE INC./Canada
JUVAF
|
$0.0262
-12.67%
-4.98%
0
|
Health Technology
(0.0% 1d) (66.7% 1m) (-40.0% 1y) (0.0% 2d) (0.0% 3d) (14.3% 7d) (-49.49% volume)
Earnings Calendar:
Market Cap: $ 3,303,457
http://www.juvalife.com
Sec Filling | Patents | n/a employees
(CA) Juva Life, Inc. engages in the cultivation, manufacturing, research and development, distribution and retail of medical and recreational cannabis. It division includes Juva Cultivation, Juva Research, Juva Manufacturing, Juva Distribution, Juva Retail, and Juva Delivery. The Juva Retail is a network of retail cannabis facilities that will serve the San Francisco Bay Area. The Juva Research is Juva's therapeutics division which, when operational, will be involved in medicinal cannabis-based product research. The Juva Manufacturing will create Juva branded and white-label products for other recreational and medical related cannabis companies. The Juva Distribution will distribute Juva branded products and products from other licensed cannabis companies. The company was founded on April 3, 2019 and is headquartered in Vancouver, Canada.
brands cannabis urea
add to watch list Paper trade email alert is off
Sino Biopharmaceutical Limited/ADR
SBMFF
|
$0.3624
64.18%
45K
|
Health Technology
(0.0% 1d) (0.0% 1m) (-33.4% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (19324.79% volume)
Earnings Calendar:
Market Cap: $ 6,813,561,124
http://www.sinobiopharm.com
Sec Filling | Patents | n/a employees
(HK) Sino Biopharmaceutical Ltd. is an investment holding company, which engages in the manufacture and sale of pharmaceutical products. It operates through the following business segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The Modernised Chinese Medicines and Chemical Medicines segment comprises the manufacturing, selling, and distribution of modernized Chinese medicine products and western medicine products. The Investment segment offers long term investments. The Other segment includes a research and development sector, which provides services to third-parties; and related healthcare and hospital business. It also develops medicines for treating tumors, analgesia, diabetes, and respiratory system diseases. The company was founded by Ping Tse on February 2, 2000 and is headquartered in Hong Kong.
respiratory diabetic diabetes
add to watch list Paper trade email alert is off
ONO PHARMACEUTICAL CO LTD
OPHLF
|
$16.64
15.62%
5.9K
|
Health Technology
(0.0% 1d) (0.0% 1m) (-20.6% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (12383.0% volume)
Earnings Calendar:
Market Cap: $ 8,609,955,328
http://www.ono.co.jp
Sec Filling | Patents | n/a employees
(JP) Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of internal medicine, patch and injectable medicine. The company was founded by Ichibei Fushimiya in 1717 and is headquartered in Osaka, Japan.
injection
add to watch list Paper trade email alert is off
Cochlear Ltd / ADR
CHEOF
|
$210.0
-6.47%
6
|
Health Technology
(0.0% 1d) (-6.2% 1m) (25.3% 1y) (-0.9% 2d) (-0.5% 3d) (0.0% 7d) (0.0% volume)
Earnings Calendar:
Market Cap: $ 13,753,759,740
http://www.cochlear.com
Sec Filling | Patents | n/a employees
(AU) Cochlear Ltd. engages in the provision of implantable hearing solutions. The firm operates through the following segments: Americas, Europe and Asia Pacific. Its products include cochlear, bone conduction and acoustic implants. The company was founded by Michael S. Hirshorn in 1981 and is headquartered in Sydney, Australia.
bone
add to watch list Paper trade email alert is off
Sinopharm Group Co/ADR
SHTDF
|
$2.54
3.25%
-29.2%
0
|
Health Technology
(0.0% 1d) (1.6% 1m) (-25.7% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (1310.53% volume)
Earnings Calendar:
Market Cap: $ 3,408,199,280
http://www.sinopharmholding.com
Sec Filling | Patents | n/a employees
(CN) Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. It operates through the following business segments: Pharmaceutical Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers and other suppliers. The Retail Pharmacy segment refers to the network of retail drug stores in major cities of China via direct operations and franchises. The Other Business segment is distributes medical devices, financial leasing ,production and sale of pharmaceutical products, chemical reagents and laboratory supplies. The company was founded on January 8, 2003 and is headquartered in Shanghai, China.
add to watch list Paper trade email alert is off
Aspen Pharmacare Holdings Ltd / ADR
APNHF
|
$9.205
25.91%
100
|
Health Technology
(0.0% 1d) (0.0% 1m) (0.1% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-88.89% volume)
Earnings Calendar:
Market Cap: $ 4,107,752,716
http://www.aspenpharma.com
Sec Filling | Patents | n/a employees
(ZA) Aspen Pharmacare Holdings Ltd. manufactures and supplies branded and generic pharmaceutical products. It operates through the following segments: Sterile Focused Brands, Anaesthetics Brands, and Thrombosis Brands. The company was founded by Michael Guy Attridge and Stephen Bradley Saad in 1850 and is headquartered in Durban, South Africa.
brands
add to watch list Paper trade email alert is off
Shandong Weigao Group Medical Polymer Co Limited/ADR
SHWGF
|
$1.67
0
|
Health Technology
(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-90.0% volume)
Earnings Calendar:
Market Cap: $ 7,552,294,440
http://www.weigaogroup.com
Sec Filling | Patents | n/a employees
(CN) Shandong Weigao Group Medical Polymer Co. Ltd. engages in the research and development, production, and sale of single-use medical devices. It operates through the following segments: Single Use Medical Device Products, Orthopedic Products, and Others. The Single Use Medical Device Products segment involves in the production and sale of single use consumables such as infusion sets, syringes, blood transfusion sets, and blood bags. The Orthopedic Products segment includes production and sale of orthopedic products such as platelet segregator, blood plasma catheter, and blood cell segregator. The Others segment consists of finance lease and factoring business. The company was founded in 1988 and is headquartered in Weihai, China.
t-cell ceiling
add to watch list Paper trade email alert is off
Shanghai Pharmaceuticals Holding Co., Ltd./ADR
SHPMF
|
$1.5435
7.55%
1.6K
|
Health Technology
(0.0% 1d) (0.0% 1m) (-20.4% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-92.99% volume)
Earnings Calendar:
Market Cap: $ 1,418,588,719
http://www.sphchina.com
Sec Filling | Patents | n/a employees
(CN) Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research and development, manufacture, distribution, and retail of pharmaceutical products. The company was founded on January 18, 1994 and is headquartered in Shanghai, China.
add to watch list Paper trade email alert is off
ConvaTec Group PLC/ADR
CNVVF
|
$3.685
-18.0%
6.4K
|
Health Technology
(0.0% 1d) (-3.0% 1m) (31.6% 1y) (0.0% 2d) (0.0% 3d) (-5.0% 7d) (2130.18% volume)
Earnings Calendar:
Market Cap: $ 7,553,474,525
http://www.convatec.com
Sec Filling | Patents | n/a employees
(GB) ConvaTec Group Plc operates as holding company, which engages in medical business. Its activities include development, manufacture and sales of medical products and technologies related to therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care and management, continence and critical care, and infusion devices used in the treatment of diabetes and other conditions. The company was incorporated in 1978 and is headquartered in Reading, the United Kingdom.
treatment diabetic diabetes
add to watch list Paper trade email alert is off
Santen Pharmaceutical Co Ltd/ADR
SNPHF
|
$9.448
-10.35%
200
|
Health Technology
(0.0% 1d) (0.0% 1m) (20.2% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (66.12% volume)
Earnings Calendar:
Market Cap: $ 3,552,375,761
http://www.santen.co.jp
Sec Filling | Patents | n/a employees
(JP) Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. It operates through the following segments: Pharmaceuticals and Others. The Pharmaceuticals segment includes prescription ophthalmic drugs, anti-rheumatic pharmaceuticals, and over-the-counter products. The Others segment offers medical equipment and devices. The company was founded by Kenkichi Tagushi in 1890 and is headquartered in Osaka, Japan.
add to watch list Paper trade email alert is off
Elekta AB / ADR
EKTAF
|
$7.56
-34.66%
1K
|
Health Technology
(0.0% 1d) (0.0% 1m) (-9.4% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-96.39% volume)
Earnings Calendar:
Market Cap: $ 2,786,522,558
http://www.elekta.com
Sec Filling | Patents | n/a employees
(SE) Elekta AB is a medical technology company. It engages in the provision of clinical solutions for the treatment of cancers and brain disorders. The firm's products and solutions include radiotherapy, stereotactic radiosurgery, oncology informatics, brachytheraphy, neurosurgery, and particle therapy. Elekta operates through the following geographical segments: North and South America; Europe, Middle East and Africa; and Asia Pacific. The company was founded by Lars Leksell and Laurent Leksell in 1972 and is headquartered in Stockholm, Sweden.
cancer treatment
add to watch list Paper trade email alert is off
Safilo Group SpA/ADR
SAFLF
|
$1.3
3.85%
10K
|
Health Technology
(0.0% 1d) (0.0% 1m) (-0.1% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (1566.67% volume)
Earnings Calendar:
Market Cap: $ 537,869,106
http://www.safilogroup.com
Sec Filling | Patents | n/a employees
(IT) Safilo Group SpA engages in the design, manufacture and distribution of prescription frames, sunglasses and sports eyewear under licensing agreements for luxury and premium brands as well as under its own brands. It operates through the Wholesale and Retail business segments. The Wholesale segment incorporates the entire business cycle of product design, research and development, production, marketing and communication, distribution, and logistics of its products. The Retail segment markets its products in specialist stores and shops worldwide. The company was founded by Guglielmo Tabacchi in 1934 and is headquartered in Padua, Italy.
brands communication
add to watch list Paper trade email alert is off
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 58% | 42% |
Top 10 Gainers
ZCMD | $1.45 5.84% 49.63% 15M
|
Commercial Services
AULT | $0.2421 -7.7% 45.23% 16M
|
Manufacturing
XPON | News | $3.15 63.21% 33.9% 100K
|
TIRX | $0.8 65.02% 25.95% 410K
|
VTNR 4 | $1.31 33.78% 25.82% 220K
|
Industrial Services
GDHG | $0.263 21.76% 25.34% 1.3M
|
TPET | $0.3279 -3.56% 23.57% 11M
|
n/a
HOLO | $2.95 31.7% 22.49% 37M
|
MTNB | $0.19 -1.04% 14.58% 950K
|
Health Technology
THCH | News | $1.28 23.08% 13.33% 79K
|
n/a
Last 48 Hours Insiders Buying
FNLC P 1275 | $22.16 -0.36% 0.34% 16K
|
Finance
|
12:30
ADMQ | $0.0532 -4.14% -40.18% 0
|
|
10:30
AXR P 2400 | $22.17 2.69% 0.0% 5.5K
|
Finance
|
21:00
QCRH P 118 | $55.41 1.34% 1.31% 54K
|
Finance
|
18:01
VUZI P 7500 | $1.26 3.28% 3.17% 930K
|
Electronic Technology
|
18:00
RMCF | $3.5501 0.57% 2.22% 18K
|
Consumer Non-Durables
|
20:10